Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Clinical Trial System 'Broken,' But Modernization Long Way Away – Woodcock

Executive Summary

CDER Director says current system is stifles innovation, calls for integration of health care and trial process.

You may also be interested in...



Real-World Data Could Get Boost From Trial Replication Project

Effort to replicate clinical trial results with real-world data could eventually allow for increased use in drug development.

Orphan Drug Development: Could We Be Seeing The End Of P Values?

Panel of experts stresses need to move toward innovative approaches for rare disease drug development such as Bayesian methods, but this would require a paradigm shift in US FDA's regulatory structure. 

Gottlieb: If Trials Show 'More Certain Benefit,' Risk Can Be Considered Long-Term

US FDA Commissioner says that with strong benefit shown, some risks can be discharged postmarket.

Related Content

Topics

UsernamePublicRestriction

Register

PS121597

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel